Hal Walsh, Brand Insights Contributor, CEO of SymmetryRx, LLC
Advertisement
Hal Walsh currently serves as the Chief Executive Officer of SymmetryRx, LLC.
As CEO, Hal provides vision, strategy, leadership, and resources to build web-based solutions to increase the reach of pharmaceutical manufacturers to healthcare providers and their patients.
Articles by Hal Walsh, Brand Insights Contributor, CEO of SymmetryRx, LLC
Advertisement
Latest Updated Articles
- Prescriber Access to Drug Samples in Virtual Environments
Published: March 15th 2021 | Updated:
- The NRx Crisis
Published: November 19th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
Cencora Accelerates Global 3PL Expansion With Major Investments in Cold Chain and Specialty Logistics
3
What MFN Pricing Means for Future Drug Development
4
Pharma Pulse: Pazdur Retires from FDA, While Public Trusts AMA Over CDC on Vaccines, and New Data Redefines Adherence as an Emotional Crisis
5
